Table 1.
Prognostic significance of CALCRL in publicly available AML gene expression data sets.
| CALCRL, Univariable | CALCRL, Multivariable | |||||
|---|---|---|---|---|---|---|
| Accession Number | HR | 95% CI | p-Value | HR | 95% CI | p-Value |
| GSE12417, cohort 1 | 2.13 | 1.38–3.3 | 0.0007 | 1.97 | 1.27–3.07 | 0.002 |
| GSE12417, cohort 2 | 2.5 | 1.4–4.5 | 0.002 | 1.76 | 0.89–3.48 | 0.105 |
| GSE6891, cohort 1 | 2.1 | 1.49–2.91 | 1.7 × 10−5 | 1.58 | 1.1–2.3 | 0.012 |
| GSE6891, cohort 2 | 2.65 | 1.8–3.9 | 6.1 × 10−7 | 2.3 | 1.5–3.4 | 6.4 × 10−5 |
| GSE37642 | 1.78 | 1.34–2.35 | 5.6 × 10−5 | 1.64 | 1.2–2.2 | 0.0007 |
| GSE71014 | 4.38 | 2.24–8.56 | 1.5 × 10−5 | n.a. | ||
| TCGA_LAML | 2.09 | 1.26–3.46 | 0.0042 | 1.63 | 0.91–2.74 | 0.066 |
HR, hazard ratio; CI, confidence interval; n.a., not applicable (no information on other prognostic parameters provided in data set). Characteristics of the data sets are summarized in Table S1.